New light device could spot skin cancer without a scalpel

NCT ID NCT02956265

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a non-invasive device that uses light to classify skin lesions as healthy, actinic keratosis, or carcinoma. Researchers aimed to see if it could help doctors diagnose skin conditions more accurately without needing a biopsy. The study involved 142 adults with suspicious skin lesions, and the device was gently placed on the skin to capture optical signals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bimodal optical spectroscopy device

What this could lead to

If successful, this device could help doctors accurately identify skin lesions without a biopsy, reducing unnecessary surgeries and scarring.

What could go wrong

This is a completed early-stage study with 142 participants, so results may not apply to all skin types or lesions. The device is not yet proven to replace standard diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

actinic keratosis in situ carcinoma invasive carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHR Metz Thionville

    Metz, 57085, France